resorcinol has been researched along with B16 Melanoma in 2 studies
resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cao, H | 1 |
Cheng, B | 1 |
Liu, T | 1 |
Chen, J | 1 |
Lee, SM | 1 |
Chen, YS | 1 |
Lin, CC | 1 |
Chen, KH | 1 |
2 other studies available for resorcinol and B16 Melanoma
Article | Year |
---|---|
Synthesis and pharmacological evaluation of novel resorcinol biphenyl ether analogs as small molecule inhibitors of PD-1/PD-L1 with benign toxicity profiles for cancer treatment.
Topics: A549 Cells; Animals; Antineoplastic Agents; B7-H1 Antigen; Coculture Techniques; Dose-Response Relat | 2021 |
Hair dyes resorcinol and lawsone reduce production of melanin in melanoma cells by tyrosinase activity inhibition and decreasing tyrosinase and microphthalmia-associated transcription factor (MITF) expression.
Topics: Ammonium Sulfate; Animals; Cell Line, Tumor; Cell Survival; Coloring Agents; Down-Regulation; Melani | 2015 |